Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)

被引:315
作者
Aiello, Stefania [1 ,2 ]
Wells, Geoffrey [3 ]
Stone, Erica L. [4 ]
Kadri, Hachemi [1 ]
Bazzi, Rana [5 ]
Bell, David R. [5 ]
Stevens, Malcolm F. G. [3 ,4 ]
Matthews, Charles S. [4 ]
Bradshaw, Tracey D. [4 ]
Westwell, Andrew D. [1 ]
机构
[1] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3NB, S Glam, Wales
[2] Univ Palermo, Fac Farm, Dipartimento Farmacochim Tossicolog & Biol, I-90123 Palermo, Italy
[3] Pharminox Ltd, Nottingham NG1 1GF, England
[4] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England
[5] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England
关键词
D O I
10.1021/jm800418z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New fluorinated 2-aryl-benzothiazoles, -benzoxazoles, and -chromen-4-ones have been synthesized and their activity against MCF-7 and MDA 468 breast cancer cell lines compared with the potent antitumor benzothiazole 5. Analogues such as 9a,b and 12a,d yielded submicromolar GI(50) values in both cell lines; however, none Of the new compounds approached 5 in terms of antitumor potency. For 5, binding to the aryl hydrocarbon receptor appeared to be necessary but not sufficient for growth inhibition.
引用
收藏
页码:5135 / 5139
页数:5
相关论文
共 24 条
[1]   The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate [J].
Bradshaw, TD ;
Westwell, AD .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (08) :1009-1021
[2]   Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines [J].
Bradshaw, Tracey D. ;
Stone, Erica L. ;
Trapani, Valentina ;
Leong, Chee-Onn ;
Matthews, Charles S. ;
Poele, Robert te ;
Stevens, Malcolm F. G. .
BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (01) :57-68
[3]   Fluorinated 2-(4-amino-3-methylphenyl) benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells [J].
Brantley, E ;
Trapani, V ;
Alley, MC ;
Hose, CD ;
Bradshaw, TD ;
Stevens, MFG ;
Sausville, EA ;
Stinson, SF .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) :1392-1401
[4]  
Chua MS, 2000, CANCER RES, V60, P5196
[5]   Parallel synthesis of a library of benzoxazoles and benzothiazoles using ligand-accelerated copper-catalyzed cyclizations of ortho-halobenzanilides [J].
Evindar, G ;
Batey, RA .
JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (05) :1802-1808
[6]   The experimental antitumor agents Phortress and Doxorubicin are equiactive against human-derived breast carcinoma xenograft models [J].
Fichtner, I ;
Monks, A ;
Hose, C ;
Stevens, MFG ;
Bradshaw, TD .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 87 (01) :97-107
[7]   Relationship between aryl hydrocarbon receptor-affinity and the induction of EROD activity by 2,3,7,8-tetrachlorinated phenothiazine and derivatives [J].
Fried, Kristian W. ;
Bazzi, Rana ;
Lopez, Walkiria Levy ;
Corsten, Claudia ;
Schramm, Karl-Werner ;
Bell, David R. ;
Rozman, Karl K. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (02) :147-155
[8]   Metabolically stabilized benzothiazoles for imaging of amyloid plaques [J].
Henriksen, Gjermund ;
Hauser, Andrea I. ;
Westwell, Andrew D. ;
Yousefi, Behrooz H. ;
Schwaiger, Markus ;
Drzezga, Alexander ;
Wester, Hans-Juergen .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (06) :1087-1089
[9]   Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs [J].
Hutchinson, I ;
Jennings, SA ;
Vishnuvajjala, BR ;
Westwell, AD ;
Stevens, MFG .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) :744-747
[10]   Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles [J].
Hutchinson, I ;
Chua, MS ;
Browne, HL ;
Trapani, V ;
Bradshaw, TD ;
Westwell, AD ;
Stevens, MFG .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (09) :1446-1455